A case of acute myocardial infarction in a multiple myeloma patient treated with Thalidomide
분야
의약학 > 내과학
저자
( Tae Jin Kim ) , ( Yeo Jin Jung ) , ( Joon Seok Park ) , ( Kil Hyun Cho )
발행기관
대한내과학회
간행물정보
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 136(총1페이지)
파일형식
42846422.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Introduction: Thalidomide was used first as a sedative and antiemetic agent. Soon Thalidomide`s teratogenic effects became apparent, and it was subsequently withdrawn from the market. However there is now a growing clinical interest in Thalidomide, and it is introduced as an antiangiogenic and immunomodulatory drug used primarily to treat multiple myeloma. Unforturately, an increase in the risk of venous thrombosis and pulmonary embolism was reported by several articles. However, arterial thrombosis associated with Thalidamide was very rare, especially coronary arteries. We report coronary arterial thrombosis induced by Thalidamide in a multiple myeloma patient. Case: A 58-year-old male patient who had been diagnosed with multiple myeloma was admitted to our cardiovascular center with chest pain. The patient``s history was unremarkable for any cardiopulmonary disease and for any cardiovascular risk factors. He has been treated with Thalidamide(200 mg/day) for 8 weeks. He had ST segments elevation in V1~V6, and poor R wave in V1~V4 and the Troponin-I and CK-MB were markedly elevated. After administration of Enoxaparin and loading dose Aspirin and Clopidogrel, he was emergently performed cardiac catherization, which revealed that total occlusion with large thrombus of distal left anterior descending artery, distal left circumflex artery and 1st diagonal artery. We performed percutaneous catheter thrombectomy and balloon angioplasty successfully and improved coronary artery flow. We also have treated with Tirofiban(Agrastat(R)) intravenously and Enoxaparin subcutaneously. We also let him stop taking Thalidomide. Meanwhile, 3 days later, the patient felt chest pain again, ST segments were elevated in all precordial leads, so we promptly performed coronary angiography that showed total occlusion at the same site of the previous study. We treated him as the same way of the past with aspiration thrombectomy and Tirofiban intravenously, Enoxaparin subcutaneuouly. The patient`s condition was stabilized after adequate treatment. 7 days later, we performed coronary angiography again that showed no evidence of occlusion. He was discharged with antiplatelets medication in stable condition without recurrence.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.